US Patent Issued to The Research Foundation for The State University of New York on Sept. 30 for "Compositions and methods to block and bind CCR2 to modulate cellular function" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,485, issued on Sept. 30, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.).

"Compositions and methods to block and bind CCR2 to modulate cellular function" was invented by Juliane Nguyen (Buffalo, N.Y.) and Michael Deci (Buffalo, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are single chain variable fragment antibodies that are directed against N-terminal or extracellular loop regions of CCR2. The scFvs can be used alone or in combination to modify macrophage number and migration and to reduce the growth of tumors."

The patent was filed on May 13, 2020, under Application No. 17/611,...